Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Treatment Refusal 1Treatment Adherence and Compliance 1Patient Compliance 1Breast Neoplasms 1

Interventions

pembrolizumab 1254Specimen Handling 869Carboplatin 818Magnetic Resonance Spectroscopy 804Cyclophosphamide 795Cisplatin 716Nivolumab 648Paclitaxel 623Radiotherapy 567Gemcitabine 565Biopsy 529Bevacizumab 468Dexamethasone 434fludarabine 404Docetaxel 373venetoclax 366Oxaliplatin 362Capecitabine 353Fluorouracil 352atezolizumab 341Rituximab 327durvalumab 326Doxorubicin 313Radiosurgery 306Pemetrexed 303Drug Therapy 295Standard of Care 292Ipilimumab 290Etoposide 280Radiation 278

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × beta-Aminoethyl Isothiourea × 1 year × Clear all
NCT05465408 2026-02-24

Culturally Aware AET Non-Initiation Intervention

Massachusetts General Hospital

Phase NA Completed
35 enrolled 7 charts
Breast

Treatment Adherence and Compliance, Breast Neoplasms, Patient Compliance, Treatment Refusal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡